Research deep-dives, engineering lessons, and perspectives on the future of autonomous scientific discovery from the Xineplus team.
Practical perspectives for teams adopting autonomous discovery workflows.
How autonomous generation, simulation, and optimization change experimental planning.
Lessons from scaling GPU-native workloads, model serving, and secure research data systems.
Technical explainers across drug discovery, materials science, proteins, and genomics.
Guides for moving AI predictions into wet-lab validation and portfolio decisions.
A practical checklist for selecting objectives, constraints, and validation gates before launching an AI discovery workflow.
How audit trails, model versions, and simulation metadata help teams trust recommendations under real research pressure.
Signals that a workflow is ready for autonomous iteration — and when human-led exploration is still the better path.
Our team summarizes the most important advances in scientific AI, from generative chemistry benchmarks to new protein design methods.
Generative chemistry, ADMET prediction, docking, and synthesis planning.
Property prediction, crystal models, digital twins, and process optimization.
Protein language models, antibodies, enzymes, stability, and lab export.
Variant interpretation, guide RNA design, vectors, and target discovery.
See new platform capabilities, SDK examples, and integration patterns as they ship.
Understand how models perform across public and partner validation datasets.
Read lessons from active discovery teams using AI in production research programs.
Posts come from the team designing models, infrastructure, and workflows behind Xineplus platforms.
Model architecture notes, benchmark interpretation, and optimization strategy.
Practical implications for chemistry, materials, protein, and genomic programs.
Production lessons for secure, scalable scientific AI systems.
Yes. Contact the team with a research question or implementation challenge you would like us to cover.
We balance accessible summaries with enough detail for scientific and engineering teams to apply the ideas.
Yes. Major platform improvements, SDK updates, and documentation releases are highlighted here.
Traditional drug discovery is linear and slow. Closed-loop AI systems that generate, simulate, and optimize autonomously are compressing timelines from years to weeks.
PINNs embed physical laws directly into neural network architectures. Here's how materials scientists can leverage them to predict properties with dramatically less training data.
Protein language models trained on evolutionary data are unlocking a new paradigm in protein engineering — designing functional proteins without explicit structural templates.
Real-world discovery problems have competing objectives. We explore Pareto-optimal approaches that let researchers navigate trade-offs instead of collapsing them into a single score.
Both approaches have a place in modern drug discovery pipelines. We break down the strengths, limitations, and ideal use cases for generative models versus screening billions of compounds.
A technical deep-dive into the architecture decisions, training strategies, and physics-based constraints that enabled our models to reach state-of-the-art accuracy on materials benchmarks.